Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Centene Co. (NYSE:CNC). In a filing disclosed on April 07th, the Representative disclosed that they had sold between $1,001 and $15,000 in Centene stock on March 31st. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Purchased $15,001 - $50,000 in shares of PTC NASDAQ: PTC on 4/1/2025.
- Sold $1,001 - $15,000 in shares of W. R. Berkley NYSE: WRB on 4/1/2025.
- Sold $15,001 - $50,000 in shares of GoDaddy NYSE: GDDY on 4/1/2025.
- Purchased $1,001 - $15,000 in shares of Ford Motor NYSE: F on 3/31/2025.
- Sold $15,001 - $50,000 in shares of Microsoft NASDAQ: MSFT on 3/31/2025.
- Sold $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 3/31/2025.
- Purchased $1,001 - $15,000 in shares of Boeing NYSE: BA on 3/31/2025.
- Sold $1,001 - $15,000 in shares of Hologic NASDAQ: HOLX on 3/31/2025.
- Sold $15,001 - $50,000 in shares of Merck & Co., Inc. NYSE: MRK on 3/31/2025.
- Sold $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 3/31/2025.
Centene Price Performance
CNC traded up $1.43 during trading on Friday, reaching $63.82. 3,887,943 shares of the stock were exchanged, compared to its average volume of 4,701,515. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The company has a market capitalization of $31.66 billion, a price-to-earnings ratio of 10.23, a P/E/G ratio of 0.80 and a beta of 0.53. Centene Co. has a 1 year low of $55.03 and a 1 year high of $80.59. The business's 50 day moving average price is $59.49 and its two-hundred day moving average price is $61.65.
Centene (NYSE:CNC - Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.31. Centene had a net margin of 2.03% and a return on equity of 13.85%. The firm had revenue of $40.81 billion during the quarter, compared to the consensus estimate of $38.78 billion. During the same period last year, the firm posted $0.45 EPS. The firm's revenue for the quarter was up 3.4% on a year-over-year basis. As a group, equities research analysts anticipate that Centene Co. will post 6.86 earnings per share for the current year.
Analysts Set New Price Targets
Several equities analysts have weighed in on the company. Guggenheim initiated coverage on Centene in a research report on Wednesday. They set a "neutral" rating for the company. Wells Fargo & Company cut their target price on shares of Centene from $76.00 to $72.00 and set an "overweight" rating for the company in a research note on Friday, February 14th. JPMorgan Chase & Co. reiterated an "overweight" rating and set a $75.00 price target (down from $80.00) on shares of Centene in a report on Tuesday, December 17th. Argus downgraded shares of Centene from a "buy" rating to a "hold" rating in a research note on Thursday, February 6th. Finally, StockNews.com upgraded Centene from a "buy" rating to a "strong-buy" rating in a report on Friday. Seven investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Centene has an average rating of "Moderate Buy" and a consensus target price of $80.85.
Get Our Latest Research Report on Centene
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. Norges Bank acquired a new position in shares of Centene during the 4th quarter valued at $1,536,167,000. Invesco Ltd. boosted its position in shares of Centene by 21.7% in the fourth quarter. Invesco Ltd. now owns 10,555,456 shares of the company's stock worth $639,450,000 after buying an additional 1,884,358 shares during the period. AQR Capital Management LLC grew its stake in shares of Centene by 42.8% in the fourth quarter. AQR Capital Management LLC now owns 7,742,698 shares of the company's stock valued at $469,053,000 after buying an additional 2,319,952 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Centene by 32.3% during the 4th quarter. Ameriprise Financial Inc. now owns 6,469,062 shares of the company's stock valued at $391,854,000 after buying an additional 1,578,917 shares during the period. Finally, Northern Trust Corp lifted its position in Centene by 9.1% during the 4th quarter. Northern Trust Corp now owns 5,294,816 shares of the company's stock worth $320,760,000 after acquiring an additional 443,121 shares in the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Centene Company Profile
(
Get Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.